The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), the first randomized trial to compare two types of digital mammography for breast cancer screening, is now open for enrollment. The study was developed by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and the National Cancer Institute (NCI), part of the National Institutes of Health. ECOG-ACRIN is leading the trial.

To expand ultrasound capabilities in its radiology department and offer safe, less invasive imaging to its pediatric patient population, OSF HealthCare Saint Francis Medical Center purchased an Aplio i800 ultrasound system from Toshiba Medical, a Canon Group company. OSF Saint Francis Medical Center, part of OSF HealthCare in Peoria, Ill., will use the system for general pediatric imaging, as well as in the neonatal intensive care unit (NICU) at OSF HealthCare Children’s Hospital of Illinois and explore new capabilities for the future.

Elekta and Brainlab have reconfirmed their alliance for the integrated use of the Elekta Versa HD linear accelerator and Brainlab ExacTrac patient positioning and monitoring technology. The integration of these two technologies offers high-definition stereotactic radiosurgery (HDRS) treatments with versatile patient positioning and monitoring through simplified workflows. A Versa HD system augmented with ExacTrac was displayed at the Elekta booth during the American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept. 24-27 in San Diego.

The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) jointly announced a partnership to develop an ASE Echocardiography Module to expand ASNC’s ImageGuide Registry. The Echo Module, ImageGuideEcho, will continue the registry’s mission to harness the power of patient data to accelerate research and technology development for improved patient outcomes in the field of cardiovascular imaging.

In 2017, invasive breast cancer will be diagnosed in about 252,710 women and 2,470 men in the U.S. and remains the second leading cause of death in women, according to the American Cancer Society. Advances in technology continue to become available to aid in the fight against breast cancer which can improve the chances of beating the disease. David Weintritt, M.D., founder of the National Breast Center and National Breast Center Foundation, recently identified the top three technologies impacting the future of breast cancer treatment to improve outcomes for women diagnosed with the disease.

October 11, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR ...

Accuray Inc. announced that data from a prospective study of 230 men with low-risk prostate cancer showed 98.4 percent had local disease control 10 years after receiving stereotactic body radiation therapy (SBRT) administered with the CyberKnife System, and toxicity was mild. The study titled, “Stereotactic Body Radiotherapy for Low-Risk Prostate Cancer: A Ten Year Analysis,” was published online in the Sept. 9, 2017 issue of Cureus.

Guerbet announced it will be taking part in the 65th edition of the Journées Francophones de Radiologie (JFR) that will be held in Paris, France, Oct. 13-16, 2017.